American International Group, Inc. Oyster Point Pharma, Inc. Transaction History

American International Group, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.6 - $11.2 $19,857 - $61,779	-5,516 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$8.58 - $17.65 $3,329 - $6,848	-388 Reduced 6.57%	5,516 $64,000
Q4 2021 Feb 11, 2022	SELL	$10.17 - $18.96 $1,810 - $3,374	-178 Reduced 2.93%	5,904 $108,000
Q3 2021 Nov 12, 2021	SELL	$11.67 - $18.07 $1,680 - $2,602	-144 Reduced 2.31%	6,082 $72,000
Q2 2021 Aug 13, 2021	BUY	$16.25 - $21.51 $43,826 - $58,012	2,697 Added 76.42%	6,226 $107,000
Q1 2021 May 07, 2021	BUY	$17.92 - $25.86 $161 - $232	9 Added 0.26%	3,529 $65,000
Q4 2020 Feb 12, 2021	SELL	$18.13 - $25.18 $1,831 - $2,543	-101 Reduced 2.79%	3,520 $66,000
Q3 2020 Nov 04, 2020	BUY	$17.83 - $29.12 $9,770 - $15,957	548 Added 17.83%	3,621 $76,000
Q2 2020 Aug 12, 2020	SELL	$27.86 - $35.93 $7,160 - $9,234	-257 Reduced 7.72%	3,073 $89,000
Q1 2020 May 04, 2020	SELL	$23.65 - $40.96 $4,564 - $7,905	-193 Reduced 5.48%	3,330 $117,000
Q4 2019 Feb 05, 2020	BUY	$13.55 - $26.15 $47,736 - $92,126	3,523 New	3,523 $86,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.